In cluster II PPGLs with loss-of-function mutations in NF1 gene, the trend for a relatively high COX-2 immunoreactivity is consistent with another report on elevated COX-2 and prostaglandin E2 (PGE2) levels in NF1 malignant peripheral nerve sheath tumors [53]. This evidence concerns the gene NF1 and cancer.